Cargando…
Blood Based Biomarkers of Central Nervous System Involvement in Wilson’s Disease
Wilson’s disease (WD) is an inherited disorder of copper metabolism with clinical symptoms related to pathological copper accumulation, which are mainly hepatic and/or neuropsychiatric. The disease is potentially treatable with pharmacological agents (chelators or zinc salts). As such, key factors f...
Autores principales: | Antos, Agnieszka, Członkowska, Anna, Bembenek, Jan, Skowronska, Marta, Kurkowska-Jastrzębska, Iwona, Litwin, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177361/ https://www.ncbi.nlm.nih.gov/pubmed/37174946 http://dx.doi.org/10.3390/diagnostics13091554 |
Ejemplares similares
-
Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
por: Litwin, Tomasz, et al.
Publicado: (2023) -
Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review
por: Litwin, Tomasz, et al.
Publicado: (2022) -
Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023) -
The Maternal and Fetal Outcomes of Pregnancy in Wilson’s Disease: A Systematic Literature Review and Meta-Analysis
por: Litwin, Tomasz, et al.
Publicado: (2022) -
D-Penicillamine-Induced Myasthenia Gravis—A Probable Complication of Wilson’s Disease Treatment—A Case Report and Systematic Review of the Literature
por: Antos, Agnieszka, et al.
Publicado: (2023)